Professional Documents
Culture Documents
a
v
e
s
c
e
n
s
1
9
9
7
C
r
u
d
e
s
u
r
f
a
c
t
i
n
H
e
x
a
d
e
c
a
n
e
,
k
e
r
o
s
e
n
e
o
i
l
S
o
i
l
B
.
s
u
b
t
i
l
i
s
M
T
C
C
2
4
2
3
1
9
9
7
B
i
o
s
u
r
f
a
c
t
a
n
t
C
r
u
d
e
o
i
l
L
i
q
u
i
d
P
.
a
e
r
u
g
i
n
o
s
a
1
9
9
7
G
l
y
c
o
l
i
p
i
d
s
(
G
L
-
K
1
2
)
A
r
o
c
h
l
o
r
1
2
4
2
S
o
i
l
P
.
c
e
p
a
c
i
a
1
9
9
7
R
h
a
m
n
o
l
i
p
i
d
P
h
e
n
a
n
t
h
r
e
n
e
,
h
e
x
a
d
e
c
a
n
e
S
o
i
l
P
.
a
e
r
u
g
i
n
o
s
a
U
G
2
1
9
9
8
M
o
n
o
r
h
a
m
n
o
l
i
p
i
d
H
e
x
a
d
e
c
a
n
e
S
a
n
d
P
.
a
e
r
u
g
i
n
o
s
a
1
9
9
8
B
i
o
s
u
r
f
a
c
t
a
n
t
P
y
r
e
n
e
S
o
i
l
c
o
l
u
m
n
s
P
.
a
e
r
u
g
i
n
o
s
a
U
G
2
1
9
9
8
R
h
a
m
n
o
l
i
p
i
d
P
A
H
s
a
n
d
P
e
n
t
a
c
h
l
o
r
o
p
h
e
n
o
l
(
P
C
P
)
S
o
i
l
P
.
a
e
r
u
g
i
n
o
s
a
#
6
4
1
9
9
9
C
r
u
d
e
s
u
r
f
a
c
t
i
n
E
n
d
o
s
u
l
f
a
n
S
o
i
l
B
.
s
u
b
t
i
l
i
s
M
T
C
C
2
4
2
3
1
9
9
9
S
u
r
f
a
c
t
i
n
H
e
a
v
y
m
e
t
a
l
s
S
o
i
l
B
.
s
u
b
t
i
l
i
s
1
9
9
9
c
o
n
t
i
n
u
e
d
o
n
n
e
x
t
p
a
g
e
272 Biosurfactants
T
a
b
l
e
5
.
C
o
n
t
i
n
u
e
d
B
i
o
s
u
r
f
a
c
t
a
n
t
S
o
u
r
c
e
R
e
m
e
d
i
a
t
i
o
n
M
e
d
i
u
m
P
o
l
l
u
t
a
n
t
Y
e
a
r
o
f
S
t
u
d
y
YY
G
l
y
c
o
l
i
p
i
d
P
C
B
S
o
i
l
A
l
c
a
n
i
v
o
r
a
x
b
o
r
k
u
m
e
n
s
i
s
1
9
9
9
A
l
a
s
a
n
P
h
e
n
a
n
t
h
r
e
n
e
,
u
o
r
a
n
t
h
e
n
e
a
n
d
p
y
r
e
n
e
L
i
q
u
i
d
A
c
i
n
e
t
o
b
a
c
t
e
r
r
a
d
i
o
r
e
s
i
s
t
e
n
s
K
A
5
3
1
9
9
9
R
h
a
m
n
o
l
i
p
i
d
s
m
i
x
t
u
r
e
t
r
i
t
o
n
X
1
0
0
T
r
i
u
r
a
l
i
n
,
c
o
u
m
a
p
h
o
s
,
a
t
r
a
z
i
n
e
l
i
q
u
i
d
P
.
a
e
r
u
g
i
n
o
s
a
U
G
2
2
0
0
0
,
2
0
0
1
C
r
u
d
e
s
u
r
f
a
c
t
i
n
A
l
i
p
h
a
t
i
c
a
n
d
a
r
o
m
a
t
i
c
h
y
d
r
o
c
a
r
b
o
n
s
S
e
a
w
a
t
e
r
B
.
s
u
b
t
i
l
i
s
O
9
2
0
0
0
S
o
p
h
o
r
o
l
i
p
i
d
P
h
e
n
a
n
t
h
r
e
n
e
S
o
i
l
C
.
b
o
m
b
i
c
o
l
a
A
T
C
C
2
2
2
1
4
2
0
0
0
R
h
a
m
n
o
l
i
p
i
d
P
h
e
n
a
n
t
h
r
e
n
e
,
c
a
d
m
i
u
m
S
o
i
l
P
.
a
e
r
u
g
i
n
o
s
a
A
T
C
C
9
0
2
7
2
0
0
0
M
o
n
o
-
r
h
a
m
n
o
l
i
p
i
d
N
a
p
h
t
h
a
l
e
n
e
,
c
a
d
m
i
u
m
S
o
i
l
P
.
a
e
r
u
g
i
n
o
s
a
A
T
C
C
9
0
2
7
2
0
0
0
D
i
-
r
h
a
m
n
o
l
i
p
i
d
T
o
l
u
e
n
e
,
e
t
h
y
l
b
e
n
z
e
n
e
,
b
u
y
t
l
b
e
n
z
e
n
e
L
i
q
u
i
d
P
s
e
u
d
o
m
o
n
a
s
s
p
2
0
0
1
R
h
a
m
n
o
l
i
p
i
d
p
o
u
l
t
r
y
l
i
t
t
e
r
c
o
i
r
p
i
t
h
g
a
s
o
l
i
n
e
s
o
i
l
P
s
e
u
d
o
m
o
n
a
s
s
p
D
S
1
0
-
1
2
9
2
0
0
2
R
h
a
m
n
o
l
i
p
i
d
H
e
x
a
d
e
c
a
n
e
S
i
l
i
c
a
m
a
t
r
i
c
e
s
P
.
a
e
r
u
g
i
n
o
s
a
U
G
2
2
0
0
2
R
h
a
m
n
o
l
i
p
i
d
s
n
-
p
a
r
a
f
n
S
o
i
l
N
o
c
a
r
d
i
o
i
d
e
s
s
p
2
0
0
2
S
a
p
o
n
i
n
M
e
t
a
l
r
e
m
e
d
i
a
t
i
o
n
S
o
i
l
P
l
a
n
t
d
e
r
i
v
e
d
2
0
0
2
B
i
o
s
u
r
f
a
c
t
a
n
t
P
A
H
s
B
a
t
c
h
s
o
l
u
t
i
o
n
s
P
.
a
e
r
u
g
i
n
o
s
a
P
C
G
3
2
0
0
3
B
i
o
s
u
r
f
a
c
t
a
n
t
g
r
o
u
n
d
r
i
c
e
h
u
l
l
s
P
A
H
s
S
o
i
l
P
.
a
e
r
u
g
i
n
o
s
a
s
t
r
a
i
n
-
6
4
2
0
0
3
R
h
a
m
n
o
l
i
p
i
d
s
b
a
c
t
e
r
i
a
l
c
o
n
s
o
r
t
i
u
m
n
u
t
r
i
e
n
t
s
n
-
a
l
k
a
n
e
s
,
P
e
t
r
o
l
e
u
m
s
l
u
d
g
e
F
l
a
v
o
b
a
c
t
e
r
i
u
m
s
p
D
S
5
-
7
3
,
P
s
e
u
d
o
m
o
n
a
s
s
p
D
S
1
0
-
1
2
9
2
0
0
3
R
h
a
m
n
o
l
i
p
i
d
s
P
C
P
s
o
i
l
J
e
n
e
i
l
b
i
o
s
u
r
f
a
c
t
a
n
t
(
s
a
u
k
v
i
l
l
e
,
W
I
,
U
S
A
)
2
0
0
3
B
O
D
B
a
l
a
n
c
e
W
a
s
t
e
w
a
t
e
r
o
i
l
s
a
n
d
g
r
e
a
s
e
l
i
q
u
i
d
C
a
c
t
u
s
2
0
0
3
c
o
n
t
i
n
u
e
d
o
n
n
e
x
t
p
a
g
e
273 Synthesis of Biosurfactants and Teir Advantages to Microorganisms and Mankind
T
a
b
l
e
5
.
C
o
n
t
i
n
u
e
d
B
i
o
s
u
r
f
a
c
t
a
n
t
S
o
u
r
c
e
R
e
m
e
d
i
a
t
i
o
n
M
e
d
i
u
m
P
o
l
l
u
t
a
n
t
Y
e
a
r
o
f
S
t
u
d
y
YY
R
h
a
m
n
o
l
i
p
i
d
s
H
e
a
v
y
m
e
t
a
l
s
S
o
i
l
J
e
n
e
i
l
b
i
o
s
u
r
f
a
c
t
a
n
t
(
s
a
u
k
v
i
l
l
e
,
W
I
,
U
S
A
)
2
0
0
3
R
h
a
m
n
o
l
i
p
i
d
H
e
x
a
d
e
c
a
n
e
L
i
q
u
i
d
R
e
n
i
b
a
c
t
e
r
i
u
m
s
a
l
m
o
n
i
n
a
r
u
m
2
7
B
N
2
0
0
4
B
i
o
s
u
r
f
a
c
t
a
n
t
P
A
H
s
S
o
i
l
P
.
a
e
r
u
g
i
n
o
s
a
P
C
G
3
2
0
0
4
R
h
a
m
n
o
l
i
p
i
d
f
o
a
m
M
e
t
a
l
s
S
o
i
l
J
e
n
e
i
l
b
i
o
s
u
r
f
a
c
t
a
n
t
(
s
a
u
k
v
i
l
l
e
,
W
I
,
U
S
A
)
2
0
0
4
R
h
a
m
n
o
l
i
p
i
d
/
S
D
S
C
r
u
d
e
o
i
l
S
t
i
r
r
e
d
t
a
n
k
R
e
a
c
t
o
r
J
e
n
e
i
l
b
i
o
s
u
r
f
a
c
t
a
n
t
s
c
o
m
p
a
n
y
,
U
S
A
2
0
0
5
B
i
o
s
u
r
f
a
c
t
a
n
t
O
i
l
S
o
i
l
R
h
o
d
o
c
o
c
c
u
s
r
u
b
e
r
2
0
0
5
B
i
o
s
u
r
f
a
c
t
a
n
t
K
e
r
o
s
e
n
e
a
n
d
d
i
s
e
l
L
i
q
u
i
d
P
s
e
u
d
o
x
a
n
t
h
o
m
o
n
a
s
k
a
o
h
s
i
u
n
g
e
n
s
i
s
2
0
0
5
R
h
a
m
n
o
l
i
p
i
d
s
P
y
r
e
n
e
S
o
i
l
P
.
a
e
r
u
g
i
n
o
s
a
5
7
S
J
2
0
0
5
274 Biosurfactants
Biodegradability and the low toxicity are the two factors which make them suitable for remediation,
but more eforts and research is required to understand their behavior in the fate and transport of
contaminants and co cocontaminants, their cost of ex situ production and the factors infuencing
the bioavailability of contaminants.
Biosurfactants and Medicine
Most of the work with applications of biosurfactants has been limited to their use in mainly
pollution control where intrinsic properties of biosurfactants are applied but they have applications
for therapeutic purposes and in medicine. Some biosurfactants, such as rhamnolipids produced
by P. aeruginosa, lipopeptides produced by Bacillus sps and yeast glycolipid mannosylerythritol
lipid (MEL) biosurfactants has numerous applications in medicine and has been shown to exhibit
properties of antimicrobial and immunological agents.
8,10,53,59
Biosurfactants have fnd applications as a cell diferentiation inducers in the human promy-
elocytic leukemia cell line HL60, as a afnity ligand of human immunoglobin G (IgG) and as a
granulocyte colony stimulating molecule.
10,53
Tere have been reports for their use as transfection
agents and are better non viral vector mediated gene transfection and gene therapy procedures.
98,99
Te use of biosurfactants as antiviral agents and antibacterial agents have been documented.
8,50,100-103
Te discovery of surfactin by Arima etal
104
was a consequence of search for antimicrobial agents
and it is one of the most potent biosurfactants known has been applied as antifungal, antibacte-
rial and antimycoplasma agent.
105
Apart from antimicrobial property surfactin has been shown
to inhibit the fbrin clot formation, inhibitor of cyclic adenosine monophosphate, platelet and
spleen cytosolic phospholipase A2 (possible role on cell signaling). Some of the other lipopeptide
biosurfactants with reported antimicrobial activity other than surfactin are iturin,
106
pumilacidin,
107
gramicidin, polymixins,
108
viscosinamide,
36,109
amphisin
110
and Massetolides A-H.
111
Applications
of glycolipids as antimicrobial agents is gaining attention in recent years. Some of the glycolipids
with antimicrobial activities are rhamnolipids of P. aeruginosa AT10,
112
glycolipids of Borrelia
burgdorferi,
113
glycolipid fungicide from Psueudozyma fusiformata
114,115
and MEL lipids Candida
antarctica.
59
Apart form these traditional applications, role of biosurfactants as probiotic agents has been
gaining interest.
116-118
Te term probiotic ofen used to describe food supplements that contain live
bacteria, which can help your health. Use of Lactobacilli, as probiotic agents has received greater
attention as an alternative, inexpensive and natural remedy to restore and maintain health.
116-118
Two strains, Lactobacillus GG (ATCC 53103) and Lactobacillus rhamnosus GR-1 appear to
be efective at decolonizing and protecting the intestine and urogenital tract against microbial
infection.
119
Te e probiotic efects of these strains are due to the byproducts (biosurfactants) of
Lactobacillus metabolism that have an antagonistic efect against urinary and vaginal pathogens.
With the increased evidence in term of more research results the concept of treating and pre-
venting urogenital infection by instillating probiotic organisms has great appeal to patients and
caregivers.
116,117,120-122
Biosurfactants have been found to inhibit the adhesion of pathogenic organisms to solid surfaces
or to infection sites
123,124
and have been shown to inhibit formation of bioflms on diferent surfaces,
including polyvivyl wells and vinyl urethral catheters.
123,125,126
Precoating the catheters and medical
devices by biosurfactant solution can and have potential applications for treating. Opportunistic
infections with Salmonella species, including urinary tract infections of AIDS patients.
10,53
Te
prior adhesion of biosurfactants to solid surfaces might constitute a new and efective means of
combating colonization by pathogenic microorganisms and a promising strategy for prolonging
the prostheses lifespan.
123-127
Biosurfactants and Miscellaneous Applications
Biosurfactants are products of interest for biotechnological and industrial applications as
discussed in previous sections and have application in many diverse areas. Role of biosurfactants
as cellular architect has recently been reported for a number of bacteria. Tey have been shown
to play role B. subtilis fruiting body formation (surfactin) and role of streptofactin in formation
275 Synthesis of Biosurfactants and Teir Advantages to Microorganisms and Mankind
Streptomyces tendae aerial mycelia. e
128,129
Tey have potential use in modern day agricultural prac-
tices as a hyrophilizing and wetting agent for achieving the equal distribution of fertilizers and
pesticides in the soils.
130,131
Tey have been applied as dewatering agents in pressing peat,
132
as dispersion agent of inor-
ganic minerals in mining and manufacturing processes,
3,5
in cosmetic formulations,
3,5
as an anti
algal agents
133,134
and as biocontrol agent.
135-138
In the food industry the biosurfactants are used as
emulsifer for the processing of raw materials.
3,5
Conclusion
Te rapid and dramatic advancement in medical and environmental sciences have increased the
public interest in natural products such as biosurfactants and propelled these molecules closer to
the mainstream of healthcare and consumer products. As explained in the chapter biosurfactants
have potent antimicrobial and environmental applications. Teir broad range of applications and
fexibility of production makes them a suitable alternative synthetic medicines and antimicrobial
agents. Tey could be applied for betterment of environment and health care. For economical
penetration of the market the biosurfactants have to overcome the cost of production by better
downstream processing and strain improvement for the upscale production. It is just matter of time
when some pharmaceutical company will invest in lowering the cost of biosurfactant production
and toxicity and other approval tests for specialty uses in medicine and will earn revenues from
introducing biosurfactants in market on large scale.
References
1. Deleu M, Paquot M. From renewable vegetables resources to microorganisms: new trends in surfactants.
Comptes Rendus Chimie 2004; 7(6-7):641-646.
2. Mulligan CN. Environmental applications for biosurfactants. Environ Pollut 2005; 133(2):183-198.
3. Desai JD, Banat IM. Microbial production of surfactants and their commercial potential. Microbiol
Mol Biol Rev 1997; 61(1):47-64.
4. Cameotra S, Makkar R. Synthesis of biosurfactants in extreme conditions. Appl Microbiol Biotechnol
1998; 50(5):520-529.
5. Banat IM, Makkar RS, Cameotra SS. Potential commercial applications of microbial surfactants. Appl
Microbiol Biotechnol 2000; 53(5):495-508.
6. Cameotra SS, Bollag J-M. Biosurfactant-Enhanced Bioremediation of Polycyclic Aromatic Hydrocarbons.
Critical Reviews in Environmental Science and Technology 2003; 30(2):111-126.
7. Lang S. Biological amphiphiles (microbial biosurfactants). Curr Opin Colloid Interface Sci 2002;
7(1-2):12-20.
8. Maier RM, Soberon-Chavez G. Pseudomonas aeruginosa rhamnolipids: biosynthesis and potential
applications. Appl Microbiol Biotechnol 2000; 54(5):625-633.
9. Makkar RS, Rockne KJ. Comparison of synthetic surfactants and biosurfactants in enhancing biodeg-
radation of polycyclic aromatic hydrocarbons. Environ Toxicol Chem 22(10):2280-2292.
10. Singh P, Cameotra SS. Potential applications of microbial surfactants in biomedical sciences. Trends
Biotechnol 2004; 22(3):142-146.
11. Georgiou G, Lin SC, Sharma MM. Surface-active compounds from microorganisms. Biotechnology
(NY) 1992; 10(1):60-65.
12. Holmberg K. Natural surfactants. Curr Opin Colloid Interface Sci 2001; 6:148-159.
13. Mulligan CN, Efekhari F. Remediation with surfactant foam of PCP-contaminated soil. Engineering
Geology 2003; 70(3-4):269-279.
14. Mulligan CN, Yong RN. Natural attenuation of contaminated soils. Environ Int 20046 2004;
30(4):587-601.
15. Ron EZ, Rosenberg E. Natural roles of biosurfactants. Environ Microbiol 2001; 3(4):229-236.
16. Maier RM. Biosurfactants: evolution and diversity in bacteria. Adv Appl Microbiol 2003;
52:101-121.
17. Bodour AA, Drees KP, Maier RM. Distribution of biosurfactant-producing bacteria in undisturbed and
contaminated arid Southwestern soils. Appl Environ Microbiol 2003; 69(6):3280-3287.
18. Rosenberg E. CRC Crit Rev Biotechnol 1986; 3:109.
19. Rosenberg E, Ron EZ. Bioemulsans: microbial polymeric emulsifers. Curr Opin Biotechnol 1997;
8(3):313-316.
20. Rosenberg E, Ron EZ. High- and low-molecular-mass microbial surfactants. Appl Microbiol Biotechnol
1999; 52(2):154-162.
276 Biosurfactants
21. Neu TR. Signifcance of bacterial surface-active compounds in interaction of bacteria with interfaces.
Microbiol Rev 1996; 60(1):151-166.
22. Zhang Y, Maier WJ, Miller RM. Efect of rhamnolipids on the dissolution, bioavailability and biodeg-
radation of phenanthrene. Environ Sci Technol 1997; 31(8):2211-2217.
23. Zhang Y, Miller RM. Efect of a Pseudomonas rhamnolipid biosurfactant on cell hydrophobicity and
biodegradation of octadecane. Appl Environ Microbiol 1994; 60(6):2101-2106.
24. Rosenberg E. Exploiting microbial growth on hydrocarbonsnew markets. Trends Biotechnol 1993;
11(10):419-424.
25. Rosenberg E, Rubinovitz C, Gottlieb A etal. Production of biodispersan by Acinetobacter calcoaceticus
A2. Appl Environ Microbiol 1988; 54:317-322.
26. Toren A, Navon-Venezia S, Ron E et al. Emulsifying Activities of Purifed Alasan Proteins from Acine-
tobacter radioresistens KA53. Appl Environ Microbiol 2001; 67(3):1102-1106.
27. Hua Z, Chen J, Lun S et al. Infuence of biosurfactants produced by Candida antarctica on surface
properties of microorganism and biodegradation of n-alkanes. Water Res 2003; 37(17):4143-4150.
28. Deziel E, Paquette G, Villemur R etal. Biosurfactant Production by a Soil Pseudomonas Strain Growing
on Polycyclic Aromatic Hydrocarbons. Appl Environ Microbiol 1996; 62(6):1908-1912.
29. Edwards DA, Luthy RG, Liu Z. Solubilization of polycyclic aromatic hydrocarbons in micellar non-ionic
surfactant solutions. Environ Sci Technol 1991; 25(1):127-133.
30. Zhang Y, Miller R. Efect of Rhamnolipid (Biosurfactant) Structure on Solubilization and Biodegrada-
tion of n-Alkanes. Appl Environ Microbiol 1995; 61(6):2247-2251.
31. Barkay T, Navon-Venezia S, Ron EZ et al. Enhancement of solubilization and biodegradation of pol-
yaromatic hydrocarbons by the bioemulsifer alasan. Appl Environ Microbiol 1999; 65(6):2697-2702.
32. Jordan RN, Nichols EP, Cunningham AB. Te role of (bio) surfactant sorption in promoting the bio-
availability of nutrients localized at the solid-water interface. Water Sci Technol 1999; 39(7):91-98.
33. Chen G, Qiao M, Zhang H et al. Bacterial desorption in water-saturated porous media in the presence
of rhamnolipid biosurfactant. Res Microbiol 2004; 155(8):655-661.
34. Puchkov EO, Zahringer U, Lindner B et al. Te mycocidal, membrane-active complex of Cryptococ-
cus humicola is a new type of cellobiose lipid with detergent features. Biochimica et Biophysica Acta
(BBA)Biomembranes 2002; 1558(2):161-170.
35. de Souza JT, de Boer M, de Waard P et al. Biochemical, Genetic and Zoosporicidal Properties of
Cyclic Lipopeptide Surfactants Produced by Pseudomonas fuorescens. Appl Environ Microbiol 2003;
69(12):7161-7172.
36. Nielsen TH, Sorensen J. Production of cyclic lipopeptides by Pseudomonas fuorescens strains in bulk
soil and in the sugar beet rhizosphere. Appl Environ Microbiol 2003; 69(2):861-868.
37. Cooper DG. Biosurfactants. Microbiol Sci 1986; 3(5):145-149.
38. Oberbremer A, Muller-Hurtig R, Wagner F. Effect of the addition of microbial surfactants on
hydrocarbon degradation in a soil population in a stirred reactor. Appl Microbiol Biotechnol 1990;
32(4):485-489.
39. Chayabutra C, Wu J, Ju LK. Rhamnolipid production by Pseudomonas aeruginosa under denitrifcation:
efects of limiting nutrients and carbon substrates. Biotechnol Bioeng 2001; 72(1):25-33.
40. Wick LY, Ruiz de Munain A, Springael D et al. Responses of Mycobacterium sp. LB501T to the low
bioavailability of solid anthracene. Appl Microbiol Biotechnol 2002; 58(3):378-385.
41. Mulligan CN, Mahmourides G, Gibbs BF. Te infuence of phosphate metabolism on biosurfactant
production by Pseudomonas aeruginosa. J Biotechnol 1989; 12(3-4):199-209.
42. Robert M, Mercade M, Bosch M et al. Efect of the carbon source on biosurfactant production by
Pseudomonas aeruginosa 44Ti. Biotechnol Lett 1989; 11:871-874.
43. Symmank H, Franke P, Saenger W et al. Modifcation of biologically active peptides: production of
a novel lipohexapeptide afer engineering of Bacillus subtilis surfactin synthetase. Protein Eng 2002;
15(11):913-921.
44. Poremba K, Gunkel W, Lang S et al. Marine biosurfactants, III. Toxicity testing with marine microor-
ganisms and comparison with synthetic surfactants. Z Naturforsch (C) 1991; 46(3-4):210-216.
45. Poremba K. Infuence of synthetic and biogenic surfactants on the toxicity of water-soluble fractions of
hydrocarbons in sea water determined with the bioluminescence inhibition test. Environ Pollut 1993;
80(1):25-29.
46. Kanga SA, Bonner JS, Page CA et al. Solubilization of Naphthalene and Methyl-Substituted Naphtha-
lenes from Crude Oil Using Biosurfactants. Environ Sci Technol 1997; 31(2):556-561.
47. Edwards KR, Lepo JE, Lewis MA. Toxicity comparison of biosurfactants and synthetic surfactants used
in oil spill remediation to two estuarine species. Mar Pollut Bull 2003; 46(10):1309-1316.
48. Banat IM. Biosurfactants, more in demand than ever: Les biosurfactants, plus que jamais sollicites.
Biofutur 2000; 198:44-47.
277 Synthesis of Biosurfactants and Teir Advantages to Microorganisms and Mankind
49. Lang S, Philp JC. Surface-active lipids in Rhodococci. Antonie Van Leeuwenhoek 1998;
74(1-3):59-70.
50. Lang S, Wullbrandt D. Rhamnose lipidsbiosynthesis, microbial production and application potential.
Appl Microbiol Biotechnol 1999; 51(1):22-32.
51. Rau U, Hammen S, Heckmann R et al. Sophorolipids: a source for novel compounds. Industrial Crops
and Products 2001; 13(2):85-92.
52. Bonmatin JM, Laprevote O, Peypoux F. Diversity among microbial cyclic lipopeptides: iturins and sur-
factins. Activity-structure relationships to design new bioactive agents. Comb Chem High Troughput
Screen 2003; 6(6):541-556.
53. Cameotra SS, Makkar RS. Recent applications of biosurfactants as biological and immunological mol-
ecules. Curr Opin Microbiol 2004; 7(3):262-266.
54. Navon-Venezia S, Zosim Z, Gottlieb A et al. Alasan, a new bioemulsifer from Acinetobacter radiore-
sistens. Appl Environ Microbiol 1995; 61(9):3240-3244.
55. Fiechter A. Biosurfactants: moving towards industrial application. Trends Biotechnol 1992;
10:208-217.
56. Zhang Y, Miller RM. Enhanced octadecane dispersion and biodegradation by a Pseudomonas rhamnolipid
surfactant (biosurfactant). Appl Environ Microbiol 1992; 58(10):3276-3282.
57. Mulligan C, Yong R, Gibbs B. Heavy metal removal from sediments by biosurfactants. J Hazard Mater
2001; 85(1-2):111-125.
58. Mulligan CN, Yong RN, Gibbs BF. Remediation technologies for metal-contaminated soils and ground-
water: an evaluation. Engineering Geology 2001; 60(1-4):193-207.
59. Kitamoto D, Isoda H, Nakahara T. Functions and potential applications of glycolipid biosurfactantsfrom
energy-saving materials to gene delivery carriers. J Biosci Bioeng 2002; 94(3):187-201.
60. Makkar RS, Cameotra SS. Synthesis of Enhanced biosurfactant by Bacillus subtilis MTCC 2423 at
45C by Foam Fractionation. Journal of Surfactants and Detergents 2001; 4:355-357.
61. Noordman WH, Bruining J-W, Wietzes P etal. Facilitated transport of a PAH mixture by a rhamnolipid
biosurfactant in porous silica matrices. J Contam Hydrol 2000; 44(2):119-140.
62. Noordman WH, Janssen DB. Rhamnolipid stimulates uptake of hydrophobic compounds by Pseudomonas
aeruginosa. Appl Environ Microbiol 2002; 68(9):4502-4508.
63. Kingston PF. Long-term Environmental Impact of Oil Spills. Spill Science and Technology Bulletin
2002; 7(1-2):53-61.
64. Page DS, Boehm PD, Brown JS et al. Mussels document loss of bioavailable polycyclic aromatic hydro-
carbons and the return to baseline conditions for oiled shorelines in Prince William Sound, Alaska.
Mar Environ Res 2005; 60(4):422-436.
65. Wiens JA. Recovery of seabirds following the Exxon Valdez oil spill: an overview. Exxon Valdez Oil
Spill: Fate and Efects in Alaskan Waters. ASTM Special Technical Publication 1995:854-893.
66. Dauvin J-C. Te fne sand Abra alba community of the bay of morlaix twenty years afer the Amoco
Cadiz oil spill. Mar Pollut Bull 1998; 36(9):669-676.
67. Urum K, Pekdemir T. Evaluation of biosurfactants for crude oil contaminated soil washing. Chemosphere
2004; 57(9):1139-1150.
68. Urum K, Pekdemir T, Ross D et al. Crude oil contaminated soil washing in air sparging assisted stirred
tank reactor using biosurfactants. Chemosphere 2005; 60(3):334-343.
69. Wei QF, Mather RR, Fotheringham AF. Oil removal from used sorbents using a biosurfactant. Bioresour
Technol 2005; 96(3):331-334.
70. Harvey S, Elashvili I, Valdes JJ et al. Enhanced removal of Exxon Valdez spilled oil from Alaskan gravel
by a microbial surfactant. Biotechnology 1990; 8(3):228-230.
71. Deschnes L, Lafrance P, Villeneuve J-P et al. Adding sodium dodecyl sulfate and Pseudomonas
aeruginosa UG2 biosurfactants inhibits polycyclic aromatic hydrocarbon biodegradation in a weathered
creosote-contaminated soil. Appl Microbiol Biotechnol 1996; 46(5-6):638-646.
72. Munoz R, Guieysse B, Mattiasson B. Phenanthrene biodegradation by an algal-bacterial consortium in
two-phase partitioning bioreactors. Appl Microbiol Biotechnol 2003; 61(3):261-267.
73. Kuyukina MS, Ivshina IB, Makarov SO et al. Efect of biosurfactants on crude oil desorption and
mobilization in a soil system. Environ Int 2005; 31(2):155-161.
74. Van Hamme JD, Singh A, Ward OP. Recent Advances in Petroleum Microbiology. Microbiol Mol Biol
Rev 2003; 67(4):503-549.
75. Khire JM, Khan MI. Microbially enhanced oil recovery (MEOR). Part 2. Microbes and the subsurface
environment for MEOR. Enzyme Microb Technol 19943 1994; 16(3):258-259.
76. Abu Ruwaida A, Banat I, Hadithirto S et al. Isolation of biosurfactant producing bacteria product
characterization and evaluation. Acta Biotechnol 1991; 11:315-324.
77. Banat I. Te Isolation of Termophilic Biosurfactant producing Bacillus sp. Biotechnol Lett 1993;
15:591-594.
278 Biosurfactants
78. Margesin R, Schinner F. Potential of halotolerant and halophilic microorganisms for biotechnology.
Extremophiles 2001; 5(2):73-83.
79. Banat IM. Biosurfactants production and possible uses in microbial enhanced oil recovery and oil pol-
lution remediation: a review. Fuel and Energy Abstracts 1995; 36(4):290.
80. Khire JM, Khan MI. Microbially enhanced oil recovery (MEOR). Part 1. Importance and mechanism
of MEOR. Enzyme Microb Technol 1994; 16(2):170-172.
81. Yakimov MM, Amro MM, Bock M et al. Te potential of Bacillus licheniformis strains for in situ
enhanced oil recovery. Journal of Petroleum Science and Engineering 1997; 18(1-2):147-160.
82. Madihah MS, Arif AB, Akmam FH et al. Hyper-thermophilic fermentative bacteria in Malaysian
petroleum reservoirs. Asia-Pacifc J Mol Biol Biotechnol 1998; 6:29-37.
83. Al-Maghrabi IMA, Bin Aqil AO, Isla MR et al. Use of thermophilic bacteria for bioremediation of
petroleum contaminants. Energy Sources 1999; 21:17-29.
84. Rahman KS, Banat IM, Tahira J et al. Bioremediation of gasoline contaminated soil by a bacterial
consortium amended with poultry litter, coir pith and rhamnolipid biosurfactant. Bioresour Technol
2002; 81(1):25-32.
85. Rahman KS, Rahman TJ, Kourkoutas Y etal. Enhanced bioremediation of n-alkane in petroleum sludge
using bacterial consortium amended with rhamnolipid and micronutrients. Bioresour Technol 2003;
90(2):159-168.
86. Makkar RS, Cameotra SS. Utilization of molasses for biosurfactant production by two Bacillus strains
at thermophilic conditions. J Am Oil Chem Soc ( JACOS) 1997; 74:887-889.
87. Makkar R, Cameotra S. An update on the use of unconventional substrates for biosurfactant production
and their new applications. Appl Microbiol Biotechnol 2002; 58(4):428-434.
88. Harrad S, Laurie L. Concentrations, sources and temporal trends in atmospheric polycyclic aromatic
hydrocarbons in a major conurbation. J Environ Monit 2005; 7(7):722-727.
89. Singh P, Cameotra SS. Enhancement of metal bioremediation by use of microbial surfactants. Biochem
Biophys Res Commun 2004; 319(2):291-297.
90. Herman DC, Zhang Y, Miller RM. Rhamnolipid (biosurfactant) efects on cell aggregation and bio-
degradation of residual hexadecane under saturated fow conditions. Appl Environ Microbiol 1997;
63(9):3622-3627.
91. Ochoa-Loza FJ, Artiola JF, Maier RM. Stability Constants for the Complexation of Various Metals with
a Rhamnolipid Biosurfactant. J Environ Qual 2001; 30(2):479-485.
92. Mulligan CN, Kamali M, Gibbs BF. Bioleaching of heavy metals from a low-grade mining ore using
Aspergillus niger. J Hazard Mater 2004; 110(1-3):77-84.
93. Maslin P, Maier RM. Rhamnolipid-Enhanced Mineralization of Phenanthrene in Organic-Metal
Cocontaminated Soils. Bioremediat J 2000; 4(4):295-308.
94. Mulligan CN, Yong RN, Gibbs BF. Removal of Heavy Metals from Contaminated Soil and Sediments
Using the Biosurfactant Surfactin. Journal of Soil Contamination 1999; 8(2):231-254.
95. Mulligan CN, Yong RN, Gibbs BF. Surfactant-enhanced remediation of contaminated soil: a review.
Engineering Geology 2001; 60(1-4):371-380.
96. Jeong-Jin H, Seung-Man Y, Choul-Ho L etal. Adsorption of tricarboxylic acid biosurfactant derived from
spiculisporic acid on titanium dioxide surface. Colloids Surf B Biointerfaces 1996; 7(5-6):221-233.
97. Finnerty WR. Biosurfactants in environmental biotechnology. Curr Opin Biotechnol 1994;
5(3):291-295.
98. Inoh Y, Kitamoto D, Hirashima N etal. Biosurfactants of MEL-A Increase Gene Transfection Mediated
by Cationic Liposomes. Biochem Biophys Res Commun 2001; 289(1):57-61.
99. Inoh Y, Kitamoto D, Hirashima N et al. Biosurfactant MEL-A dramatically increases gene transfection
via membrane fusion. J Control Release 2004; 94(2-3):423-431.
100. Vollenbroich D, Ozel M, Vater J et al. Mechanism of Inactivation of Enveloped Viruses by the Biosur-
factant Surfactin from Bacillus subtilis. Biologicals 1997; 25(3):289-297.
101. Vollenbroich D, Pauli G, Ozel M et al. Antimycoplasma properties and application in cell culture of
surfactin, a lipopeptide antibiotic from Bacillus subtilis. Appl Environ Microbiol 1997; 63(1):44-49.
102. Lang S, Kaiswela E, F W. Antimicrobial efects of biosurfactants. Fat Sci Technol 1989; 91:363-366.
103. Lang S, Wagner F. Biological Activities of Biosurfactants. New York: Marcel Dekker INc; 1993.
104. Arima K, Kakinuma A, Tamuri G. Surfactin, a crystalline peptidolipid surfactant produced by Bacillus
subtilis. Isolation, Characterization and its inhibition of fbrin clot formation. Biochem Biophys Res
Comm 1968; 31:361-369.
105. Nir-Paz R, Prevost MC, Nicolas P et al. Susceptibilities of Mycoplasma fermentans and Mycoplasma
hyorhinis to membrane-active peptides and enrofoxacin in human tissue cell cultures. Antimicrob Agents
Chemother 2002; 46(5):1218-1225.
106. Sandrin C, Peypoux F, Michel G. Coproduction of surfactin and iturin A, lipopeptides with surfactant
and antifungal properties, by Bacillus subtilis. Biotechnol Appl Biochem 1990; 12(4):370-375.
279 Synthesis of Biosurfactants and Teir Advantages to Microorganisms and Mankind
107. Naruse N, Tenmyo O, Kobaru S et al. Pumilacidin, a complex of new antiviral antibiotics: production,
isolation, chemical properties, structure and biological activity. J Antibiot (Tokyo) 1990; 43:267-280.
108. Kitatsuji K, Miyata H, Fukase T. Isolation of microorganisms that lyse flamentous bacteria and character-
ization of the lytic substance secreted by Bacillus polymyxa. J Ferment Bioeng 1996; 82(4):323-327.
109. Nielsen TH, Sorensen D, Tobiasen C etal. Antibiotic and biosurfactant properties of cyclic lipopeptides
produced by fuorescent Pseudomonas spp. from the sugar beet rhizosphere. Appl Environ Microbiol
2002; 68(7):3416-3423.
110. Andersen JB, Koch B, Nielsen TH et al. Surface motility in Pseudomonas sp. DSS73 is required for
efcient biological containment of the root-pathogenic microfungi Rhizoctonia solani and Pythium
ultimum. Microbiology 2003; 149:37-46.
111. Gerard J, Lloyd R, Barsby T et al. Massetolides A-H, antimycobacterial cyclic depsipeptides produced
by two Pseudomonads isolated from marine habitats. J Nat Prod 1997; 60(3):223-229.
112. Abalos A, Pinazo A, Infante MR et al. Physicochemical and Antimicrobial Properties of New Rhamno-
lipids Produced by Pseudomonas aeruginosa AT10 from Soybean Oil Refnery Wastes. Langmuir 2001;
17(5):1367-1371.
113. Hossain H, Wellensiek H-J, Geyer R et al. Structural analysis of glycolipids from Borrelia burgdorferi.
Biochimie 2001; 83(7):683-692.
114. Golubev WI, Kulakovskaya TV, Golubeva EW. Te yeast Pseudozyma fusiformata VKM Y-2821 produc-
ing an antifungal glycolipid. Microbiol 2001; 70:553-556.
115. Kulakovskaya TV, Kulakovskaya EV, Golubev WI. ATP leakage from yeast cells treated by extracellular
glycolipids of Pseudozyma fusiformata. FEMS Yeast Research 2003; 3(4):401-404.
116. Reid G, Bruce AW, Fraser N et al. Oral probiotics can resolve urogenital infections. FEMS Immunol
Med Microbiol 2001; 30(1):49-52.
117. Reid G, Heinemann C, Velraeds M et al. Biosurfactants produced by Lactobacillus. Methods Enzymol
1999; 310:426-433.
118. Gan BS, Kim J, Reid G et al. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection
of surgical implants in rats. J Infect Dis 2002; 185(9):1369-1372.
119. Reid G, Charbonneau D, Erb J et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum
RC-14 signifcantly alters vaginal fora: randomized, placebo-controlled trial in 64 healthy women.
FEMS Immunol Med Microbiol 2003; 35(2):131-134.
120. Rastall RA, Gibson GR, Gill HS et al. Modulation of the microbial ecology of the human colon by
probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and
potential applications. FEMS Microbiol Ecol 2005; 52(2):145-152.
121. Reid G. Te Scientifc Basis for Probiotic Strains of Lactobacillus. Appl Environ Microbiol 1999;
65(9):3763-3766.
122. Reid G. Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr 2001;
73(2 Suppl):437S-443S.
123. Velraeds MM, van de Belt-Gritter B, Busscher HJ et al. Inhibition of uropathogenic bioflm growth
on silicone rubber in human urine by lactobacillia teleologic approach. World J Urol 2000;
18(6):422-426.
124. van Hoogmoed CG, van der Mei HC, Busscher HJ. Te infuence of biosurfactants released by S. mitis
BMS on the adhesion of pioneer strains and cariogenic bacteria. Biofouling 2004; 20(6):261-267.
125. Meylheuc T, van Oss C, Bellon-Fontaine M. Adsorption of biosurfactant on solid surfaces and
consequences regarding the bioadhesion of Listeria monocytogenes LO28. J Appl Microbiol 2001;
91(5):822-832.
126. Rodrigues L, Van Der Mei H, Teixeira JA et al. Biosurfactant from Lactococcus lactis 53 inhibits
microbial adhesion on silicone rubber. Appl Microbiol Biotechnol 2004.
127. Batrakov SG, Rodionova TA, Esipov SE et al. A novel lipopeptide, an inhibitor of bacterial adhesion,
from the thermophilic and halotolerant subsurface Bacillus licheniformis strain 603. Biochimica et
Biophysica Acta (BBA)Molecular and Cell Biology of Lipids 2003; 1634(3):107-115.
128. Branda SS, Gonzalez-Pastor JE, Ben-Yehuda S et al. Fruiting body formation by Bacillus subtilis. Proc
Natl Acad Sci USA 2001; 98(20):11621-11626.
129. Richter M, Willey JM, Su(ss)muth R et al. Streptofactin, a novel biosurfactant with aerial mycelium
inducing activity from Streptomyces tendae Tu 9018c. FEMS Microbiol Lett 1998; 163(2):165-171.
130. Mata-Sandoval JC, Karns J, Torrents A. Infuence of rhamnolipids and triton X-100 on the desorption
of pesticides from soils. Environ Sci Technol 2002; 36(21):4669-4675.
131. Awashti N, Kumar A, Makkar R et al. Enhanced Biodegradation of endosulfan, a chlorinated pesticide
in presence of a biosurfactant. J Environ Sci Health 1999; 34:793-803.
132. Cooper DG, Pillon DW, Mulligan CN et al. Biological additives for improved mechanical dewatering
of fuel-grade peat. Fuel 1986; 65(2):255-259.
280 Biosurfactants
133. Ahn C-Y, Joung S-H, Jeon J-W et al. Selective control of cyanobacteria by surfactin-containing culture
broth of Bacillus subtilis C1. Biotechnol Lett 2003; 25(14):1137-1142.
134. Wang X, Gong L, Liang S etal. Algicidal activity of rhamnolipid biosurfactants produced by Pseudomonas
aeruginosa. Harmful Algae 2005; 4(2):433-443.
135. Souto GI, Correa OS, Montecchia MS et al. Genetic and functional characterization of a Bacillus sp.
strain excreting surfactin and antifungal metabolites partially identifed as iturin-like compounds. J Appl
Microbiol 2004; 97(6):1247-1256.
136. Assie LK, Deleu M, Arnaud L et al. Insecticide activity of surfactins and iturins from a biopesticide
Bacillus subtilis Cohn (S499 strain). Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet 2002;
67(3):647-655.
137. Ongena M, Duby Fl, Jourdan E et al. Bacillus subtilis M4 decreases plant susceptibility towards fungal
pathogens by increasing host resistance associated with diferential gene expression. Appl Microbiol
Biotechnol 2005; 67(5):692-698.
138. Toure Y, Ongena M, Jacques P et al. Role of lipopeptides produced by Bacillus subtilis GA1 in
the reduction of grey mould disease caused by Botrytis cinerea on apple. J Appl Microbiol 2004;
96(5):1151-1160.